| Literature DB >> 29683372 |
Keiichi Izumikawa1, Hideaki Ishikawa1, Richard J Simpson2,3, Nobuhiro Takahashi1,2.
Abstract
Chtop binds competitively to the arginine methyltransferases PRMT1 and PRMT5, thereby promoting the asymmetric or symmetric methylation of arginine residues, respectively. In cooperation with PRMT1, Chtop activates transcription of certain gene groups, such as the estrogen-inducible genes in breast cancer cells, the 5-hydroxymethylcytosine-modified genes involved in glioblastomagenesis, or the Zbp-89-dependent genes in erythroleukemia cells. Chtop also represses expression of the fetal γ-globin gene. In addition, Chtop is a component of the TREX complex that links transcription elongation to mRNA export. The regulation of Chtop expression is, therefore, a key process during the expression of certain gene groups and pathogenesis of certain diseases. Our recent study revealed that cellular levels of Chtop are strictly autoregulated by a mechanism involving intron retention and nonsense-mediated mRNA decay. Here, we summarize roles of Chtop in gene-specific expression and highlight our recent findings concerning the autoregulation of Chtop.Entities:
Keywords: NMD; PRMT1; PRMT5; chtop; glioblastoma; intron retention; mRNA export; splicing; transcription; β-thalassemia
Mesh:
Substances:
Year: 2018 PMID: 29683372 PMCID: PMC6161726 DOI: 10.1080/15476286.2018.1465795
Source DB: PubMed Journal: RNA Biol ISSN: 1547-6286 Impact factor: 4.652